Unique ID issued by UMIN | UMIN000040121 |
---|---|
Receipt number | R000045747 |
Scientific Title | The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer |
Date of disclosure of the study information | 2020/04/15 |
Last modified on | 2024/03/20 16:07:52 |
The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer
The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer
The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer
The prospective study of focal high-dose rate brachytherapy for primary clinically localized prostate cancer
Japan |
Prostate cancer
Urology |
Malignancy
NO
1.The safety for focal high-dose rate brachytherapy using Irisium for clinically localized prostate cancer
2.The efficacy for pathological evaluation of re-biopsy of focal radiation region
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
1.The safety for focal high-dose rate brachytherapy using Irisium for clinically localized prostate cancer
2.The efficacy for pathological evaluation of re-biopsy of focal radiation region
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Focal high-dose rate brachytherapy for Prostate using Irisium
20 | years-old | <= |
Not applicable |
Male
1.Only single region prostate cancer revealed same region, that suspcet of clinically significant cancer by mpMRI prior biopsy
2.Prostate cancer diagnosed pathological examination
3.Proatate cancer of Gleason score 3+3 or 3+4
4.Not ever accepte the therapy for prostate cancer
5.No metastasis region by radiological examination
6.PSA value less than 20ng/ml
7.Performance Status is 0, 1 or2
1.Prostate cancer region close to rectal wall
2.multiple cancer region diagnosed by prostate biopsy
3.Medical history for radiation therapy of the pelvis
4.Unfit for regularly MRI examination for follow-up
5.Administration of glucocorticoid or 5-arufa reductase
6.Actively double cancer
12
1st name | Yoshiyuki |
Middle name | |
Last name | Miyaji |
Kawasaki Medical School Hospital
Urology
701-0192
577, Matsushima, Kurashiki, Japan
086-462-1111
miyaji@med.kawasaki-m.ac.jp
1st name | Yoshiyuki |
Middle name | |
Last name | Miyaji |
Kawasaki Medical School Hospital
Urology
701-0192
577, Matsushima, Kurashiki, Japan
086-462-1111
miyaji@med.kawasaki-m.ac.jp
Kawasaki Medical School Hospita, Department of Urology
Kawasaki Medical School Hospita, Department of Urology
Other
The ethics committee of Kawasaki Medical School and Hospital
577, Matsushima, Kurashiki, Japan
086-462-1111
kmsrec@med.kawasaki-m.ac.jp
NO
2020 | Year | 04 | Month | 15 | Day |
Unpublished
No longer recruiting
2020 | Year | 02 | Month | 08 | Day |
2020 | Year | 04 | Month | 17 | Day |
2020 | Year | 04 | Month | 17 | Day |
2024 | Year | 08 | Month | 31 | Day |
2020 | Year | 04 | Month | 09 | Day |
2024 | Year | 03 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045747
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |